Dr. Takeshi Yoshimoto | Stroke with Cancer | Best Researcher Award
University of Tsukuba Hospital | Japan
Author Profile
Dr. Takeshi Yoshimoto š§ š
š¬ Research Interests
Dr. Takeshi Yoshimoto is a dedicated researcher and clinician focused on advancing stroke treatment through cutting-edge translational research. His work centers on:
- Development of algorithms for clot removal devices in acute stroke by rapidly identifying genetic variations and serum biomarkers.
- Exploration of juvenile stroke and its association with the RNF213 p.R4810K polymorphism linked to Moyamoya disease.
- Innovative stroke therapies aimed at improving patient outcomes.
š Education
- Ph.D. in Biomedical and Health Sciences – Hiroshima University, Japan (August 2022)
- M.D. – Hiroshima University Faculty of Medicine, Japan (March 2008)
š¼ Professional Experience
- April 2024 ā Present: Lecturer, Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital
- August 2018 ā March 2024: Medical Doctor, Department of Neurology, National Cerebral and Cardiovascular Center
- April 2018 ā July 2018: Senior Resident, Department of Neurology, National Cerebral and Cardiovascular Center
- April 2015 ā March 2018: Resident, Department of Neurology, National Cerebral and Cardiovascular Center
- April 2013 ā March 2015: Neurologist, Ota Memorial Hospital
- April 2012 ā March 2013: Neurologist, Hiroshima University Graduate School of Biomedical & Health Sciences
- April 2009 ā March 2012: Intern, Fukushima Coop Hospital
š Honors & Awards
- Outstanding Presentation Award, Cardiovascular Stroke Society of Japan (2022)
- Paul Dudley White International Scholar Award, American Heart Association (2021)
- Outstanding Paper Award, Japanese Society of Neuroendovascular Therapy (2021)
- Teaching Award, National Cerebral and Cardiovascular Center (2019)
- Multiple awards for oral presentations at the Japan Stroke Society Annual Meetings (2019, 2022)
š Research Grants
Dr. Yoshimoto has successfully led several grant-funded projects, including:
- Development of selection algorithms for clot removal devices in acute stroke (JSNET, 2019ā2026)
- Novel cerebrovascular treatment via SIRT1 gene activation (Japan Heart Foundation, 2020ā2022)
š Key Research Support
- 2024ā2026: Grant-in-Aid, JSNET ā Development of selection algorithm for clot removal devices (1,000,000 JPY)
- 2020ā2022: Grant-in-Aid, Japan Heart Foundation ā Novel treatments for cerebrovascular disorders (2,000,000 JPY)
āØ Conclusion
Dr. Takeshi Yoshimoto is a leading neurologist and researcher with a profound dedication to advancing the treatment of stroke and cerebrovascular diseases. His work, combining clinical expertise with innovative translational research, is driving new developments in the rapid diagnosis and treatment of acute stroke. Through his focus on genetic variations and novel therapeutic methods, Dr. Yoshimoto is shaping the future of stroke care, aiming for improved outcomes for patients worldwide. His contributions, backed by numerous awards and research grants, highlight his commitment to excellence in both academic and clinical spheres.
šš¬NOTABLE PUBLICATION:
- Long-Term Resveratrol Intake for Cognitive and Cerebral Blood Flow Impairment in Carotid Artery Stenosis/Occlusion
- Authors: Hattori, Y., Kakino, Y., Hattori, Y., Iida, H., Ihara, M.
- Journal: Journal of Stroke
- Year: 2024
- RNF213 p.R4810K Variant Increases the Risk of Vasospastic Angina
- Authors: Ishiyama, H., Tanaka, T., Yoshimoto, T., Noguchi, T., Ihara, M.
- Journal: JACC: Asia
- Year: 2023
- Expanding the Treatable Imaging Profile in Patients with Large Ischemic Stroke: Subanalysis from a Randomized Clinical Trial
- Authors: Inoue, M., Yoshimoto, T., Yamagami, H., Morimoto, T., Yoshimura, S.
- Journal: Stroke
- Year: 2024
- REsveratrol for VAscular Cognitive Impairment Investigating Cerebral Metabolism and Perfusion (REVAMP trial): A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial
- Authors: Hattori, Y., Minami, M., Omae, K., Iida, H., Ihara, M.
- Journal: Frontiers in Nutrition
- Year: 2024
- Association of Thyroid Peroxidase Antibody with the RNF213 p.R4810K Variant in Ischemic Stroke/Transient Ischemic Attack
- Authors: Yoshimoto, T., Ishiyama, H., Hattori, Y., Koga, M., Ihara, M.
- Journal: Atherosclerosis
- Year: 2023